Ainos Named Exclusive Sales Partner for COVID-19 Antigen Rapid Test Kit in Taiwan
SAN DIEGO, CA / ACCESSWIRE / June 14, 2021 / Ainos, Inc. ('we', 'our', or the 'Company'), (OTC PINK:AIMD), entered into an exclusive agreement to serve as the master sales and marketing agent for the Ainos...
Ainos Announces FINRA Approval of Name Change and Ticker Symbol Change to "AIMD", Engages Firm to Explore Listing Requirements of National Securities Exchanges
SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Ainos, Inc., f/k/a Amarillo Biosciences, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), is pleased to announce that the Financial Industry Regulatory...
Amarillo Biosciences, Inc. Announced Closing under Securities Purchase Agreement with Majority Investor and Name Change to "Ainos, Inc."
AMARILLO, TX / ACCESSWIRE / April 21, 2021 / Ainos, Inc., f/k/a Amarillo Biosciences, Inc. ("we" or the "Company"), (OTCBB:AMAR), a company engaged in the discovery and development of pharmaceutical and...